Diagnostics & Tools March 2020

Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.

• QIAGEN N.V. to be acquired by Thermo Fisher Scientific
• Diploid was acquired by Invitae
• TeraRecon was acquired by SymphonyAI
• Marker Gene Technologies was acquired by Abcam
• Tempus Labs received $100 Million in Series G Financing